R&D Systems Human Crossveinless-2/CV-2 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems 1956CV050/CF
DescriptionThe Recombinant Human Crossveinless-2 Protein is derived from NS0. The Recombinant Human Crossveinless-2 Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|95%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Mouse myeloma cell line,NS0-derived human Crossveinless-2/CV-2 protein Val34-Asp369,with an N-terminal 7-His tag & Ala39-Asp369 (N-terminal fragments) & Pro370-Arg685 (C-terminal fragment)|